Written Question·Department of Health and Social Care·UIN 1335

Trastuzumab Deruxtecan

Tabled: 23 July 2024
Answered: 19 August 2024
Named Day

Question

Tonia Antoniazzi

LabourGower

To ask the Secretary of State for Health and Social Care, whether he has had discussions with his counterparts in (a) Scotland, (b) Wales and (c) Northern Ireland on access to Enhertu for patients with HER2-low breast cancer.

Answer

Karin Smyth
My Rt hon. Friend, the Secretary of State for Health and Social Care, spoke with his counterparts in Scotland and Wales on his first full day in office and will continue to engage with them on a regular basis. However decisions on the availability of indi...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 1335) →